CA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Published online before print June 16, 2010
CA Cancer J Clin 2010; 60:207-221
doi: 10.3322/caac.20078
© 2010 American Cancer Society
This Article
Right arrow Full Text Freely available
Right arrow Full Text (PDF) Freely available
Right arrow All Versions of this Article:
caac.20078v1
60/4/207    most recent
Right arrow Submit a Comment to the editor
Right arrow Comments: View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when Comments are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Giovannucci, E.
Right arrow Articles by Yee, D.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Giovannucci, E.
Right arrow Articles by Yee, D.

Diabetes and Cancer: A Consensus Report

Edward Giovannucci, MD, ScD1, David M. Harlan, MD2, Michael C. Archer, MA, PhD, DSC3, Richard M. Bergenstal, MD4, Susan M. Gapstur, PhD5, Laurel A. Habel, PhD6, Michael Pollak, MD7, Judith G. Regensteiner, PhD8 and Douglas Yee, MD9

1Departments of Nutrition and Epidemiology, Harvard School of Public Health, Boston, MA
2Diabetes Center of Excellence, University of Massachusetts Memorial Medical Center and Departments of Medicine and Pediatrics, University of Massachusetts Medical School, Worcester, MA
3Departments of Nutritional Sciences and Medical Biophysics, Faculty of Medicine, University of Toronto, Toronto, ON, Canada
4International Diabetes Center at Park Nicollet, Minneapolis, MN
5Epidemiology Research Program, American Cancer Society, Atlanta, GA
6Division of Research, Kaiser Permanente, Oakland, CA
7Department of Oncology, McGill University, Montreal, QC, Canada
8University of Colorado School of Medicine, Aurora, CO
9Masonic Cancer Center, University of Minnesota, Minneapolis, MN

Corresponding author: Edward Giovannucci, MD, ScD, Departments of Nutrition and Epidemiology, Harvard School of Public Health, 655 Huntington Avenue, Boston, MA, 02115; egiovann{at}hsph.harvard.edu

DISCLOSURES: Dr. Giovannucci and Dr. Harlan are Writing Group co-chairs. Dr. Bergenstal has served on scientific advisory boards or as a consultant to Medtronic, Abbott, Bayer Diabetes Care, Eli Lilly, Intuity Medical, MannKind, Novo Nordisk, Roche, Sanofi-Aventis, and Valeritas; has received research support from Amylin, Bayer Diabetes Care, Eli Lilly, MannKind, Medtronic, the National Institutes of Health (NIH), Novo Nordisk, ResMed, and LifeScan; and is a joint stockholder in Merck. Dr. Habel has received research support from Takeda, Merck, Genetech (Roche), and Sanofi-Aventis. Dr. Pollak has received research support from Pfizer and serves as a consultant to Sanofi-Aventis and Novo Nordisk. Dr. Regensteiner has received research support from the NIH and the American Diabetes Association and has received honoraria from the University of Colorado at Denver. Dr.Yee has served on the advisory board of Novo Nordisk. No other potential conflict of interest relevant to this article was reported.

Epidemiologic evidence suggests that cancer incidence is associated with diabetes as well as certain diabetes risk factors and treatments. This consensus statement of experts assembled jointly by the American Diabetes Association and the American Cancer Society reviews the state of science concerning 1) the association between diabetes and cancer incidence or prognosis; 2) risk factors common to both diabetes and cancer; 3) possible biologic links between diabetes and cancer risk; and 4) whether diabetes treatments influence the risk of cancer or cancer prognosis. In addition, key unanswered questions for future research are posed. CA Cancer J Clin 2010. © 2010 American Cancer Society, Inc.




This article has been cited by other articles:


Home page
 Cancer Prevention ResearchHome page
M. Pollak
Metformin and Other Biguanides in Oncology: Advancing the Research Agenda
Cancer Prevention Research, September 1, 2010; 3(9): 1060 - 1065.
[Abstract] [Full Text] [PDF]

Home page
 QJMHome page
T. A. Chowdhury
Diabetes and Cancer
QJM, August 25, 2010; (2010) hcq149v1.
[Abstract] [Full Text] [PDF]

Comments:

Read all Comments

Diabetes and cancer - how diabetes affects treatment
PAUL G CORNES
CA Online, 23 Jul 2010 [Full text]
Cancer treatment may either cause diabetes or worsen a pre-existing diabetes.
Hong-Mei Zhang, et al.
CA Online, 29 Jul 2010 [Full text]
Dose diabetes really increase risk of cancer?
Yuesheng Xia, et al.
CA Online, 29 Jul 2010 [Full text]
Change of internal environment: a common treat of Diabetes and Cancer
Chao Wang
CA Online, 29 Jul 2010 [Full text]
Vitamin D deficiency: the biological linker between diabetes and cancer
Huan Wang, et al.
CA Online, 2 Aug 2010 [Full text]
Leptin may be an other possible biologic link between diabetes and cancer risk
Hua Zhang, et al.
CA Online, 10 Aug 2010 [Full text]
The depression of emotion is a risk factor of diabetes and cancer
Wenli Hai, et al.
CA Online, 18 Aug 2010 [Full text]
Statin therapy in diabetes: Association with carcinogenesis
Guo-Dong Gao, et al.
CA Online, 18 Aug 2010 [Full text]

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2010 by American Cancer Society.